Skip Navigation



IJE Advance Access published online on January 27, 2007
International Journal of Epidemiology, doi:10.1093/ije/dyl305
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
36/1/29    most recent
dyl305v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Young, T.
Right arrow Articles by Heyns, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, T.
Right arrow Articles by Heyns, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2007; all rights reserved.

COCHRANE COLUMN

Taryn Young

South African Cochrane Centre, Medical Research Council, PO Box 19070, Tygerberg 7505, South Africa. Email: taryn.young@mrc.ac.za

The first 150 words of the full text of this article appear below.

This month we feature the Cochrane Review assessing the effects of screening in reducing prostate-specific and all-cause mortality.

The aim of the Column is to highlight Cochrane Reviews of relevance to public health, and to stimulate debate on relevance, feasibility and acceptability. The Cochrane Collaboration (http://www.cochrane.org) is an international, non-profit organization that prepares and disseminates up-to-date systematic reviews on the effects of healthcare interventions in order to help people make well-informed decisions. Systematic reviews aim to answer focused healthcare questions by systematically identifying and evaluating all relevant research studies and synthesizing their results.

Formula

If you are interested in contributing to the Cochrane Column or The Cochrane Collaboration, contact me at the South African Cochrane Centre.

 

Screening for prostate cancer

Dragan Ilic1, Denise O'Connor1, Sally Green1 and Timothy Wilt2

1 Monash Institute of Health Services Research, Monash University, Clayton VIC 3168 Australia.
2 Minneapolis VA Center for Chronic Disease Outcomes Research, Minneapolis, MN 55417, USA.

Prostate cancer is a common cause of cancer in men worldwide. There is debate around the effectiveness of screening methods for prostate cancer—around the digital rectal examination (DRE) and prostate specific antigen (PSA) . . . [Full Text of this Article]

Jenny Donovan and Richard Martin

Department of Social Medicine, University of Bristol, UK.

CF Heyns

Department of Urology, University of Stellenbosch and Tygerberg Hospital, Cape Town, South Africa.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?